Skip to main content

JANE STREET GROUP, LLC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in LXEO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$0
-$1,391,152 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
8 quarters on record

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Derivatives in LXEO

reported options exposure · as of Mar 31, 2026
CallValue
$142,926
CallShares
24,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $142,926 24,900
2025-12-31 $1,391,152 140,096
2025-09-30 $859,694 129,472
2024-12-31 $95,488 14,512
2024-09-30 $322,519 35,677
2024-06-30 $429,214 26,759
2024-03-31 $626,149 39,933
2023-12-31 $522,843 38,960